ATE126792T1 - 3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie. - Google Patents
3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie.Info
- Publication number
- ATE126792T1 ATE126792T1 AT90402891T AT90402891T ATE126792T1 AT E126792 T1 ATE126792 T1 AT E126792T1 AT 90402891 T AT90402891 T AT 90402891T AT 90402891 T AT90402891 T AT 90402891T AT E126792 T1 ATE126792 T1 AT E126792T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- alkyl
- chain
- groups
- oxazolidinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8913555A FR2653017B1 (fr) | 1989-10-17 | 1989-10-17 | Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE126792T1 true ATE126792T1 (de) | 1995-09-15 |
Family
ID=9386480
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90402891T ATE126792T1 (de) | 1989-10-17 | 1990-10-16 | 3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie. |
AT90402892T ATE126220T1 (de) | 1989-10-17 | 1990-10-16 | 3-aryl-oxazolidinone-derivate, verfahren zu ihrer herstellung und ihre anwendung in der therapie. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90402892T ATE126220T1 (de) | 1989-10-17 | 1990-10-16 | 3-aryl-oxazolidinone-derivate, verfahren zu ihrer herstellung und ihre anwendung in der therapie. |
Country Status (16)
Country | Link |
---|---|
US (3) | US5036091A (de) |
EP (3) | EP0424244B1 (de) |
JP (3) | JPH04502335A (de) |
KR (3) | KR0149508B1 (de) |
AT (2) | ATE126792T1 (de) |
AU (3) | AU637150B2 (de) |
CA (3) | CA2027783C (de) |
DE (2) | DE69021823T2 (de) |
DK (1) | DK0424244T3 (de) |
ES (1) | ES2078958T3 (de) |
FR (1) | FR2653017B1 (de) |
GR (1) | GR3017708T3 (de) |
HK (1) | HK1005591A1 (de) |
NZ (3) | NZ235728A (de) |
WO (3) | WO1991005775A1 (de) |
ZA (3) | ZA908283B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2653017B1 (fr) * | 1989-10-17 | 1995-05-05 | Delalande Sa | Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique. |
US5196543A (en) * | 1989-10-17 | 1993-03-23 | Delalande S.A. | 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy |
US5235063A (en) * | 1989-10-17 | 1993-08-10 | Delalande S.A. | Process of preparing by condensation certain |
FR2675504B1 (fr) * | 1991-04-16 | 1995-01-27 | Delalande Sa | Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique. |
TW286317B (de) * | 1993-12-13 | 1996-09-21 | Hoffmann La Roche | |
FR2715155B1 (fr) * | 1994-01-19 | 1996-07-26 | Mayoly Spindler | Inhibiteurs de la monoamine oxydase B et leurs procédés de préparation. |
FR2732679B1 (fr) * | 1995-04-07 | 1997-04-30 | Synthelabo | Procede de preparation enzymatique d'un intermediaire de synthese de la befloxatone |
FR2734821B1 (fr) * | 1995-06-02 | 1997-07-11 | Synthelabo | Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique |
AU699367B2 (en) * | 1995-06-02 | 1998-12-03 | Sanofi-Aventis | Isoindole derivatives, their preparation and their application in therapy |
FR2734820B1 (fr) * | 1995-06-02 | 1997-07-11 | Synthelabo | Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique |
FR2737206B1 (fr) * | 1995-07-24 | 1997-08-22 | Synthelabo | Derives d'oxazoloquinoleinone, leur preparation et leur application en therapeutique |
FR2741072B1 (fr) * | 1995-11-09 | 1997-12-12 | Synthelabo | Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique |
FR2741071B1 (fr) * | 1995-11-09 | 1997-12-12 | Synthelabo | Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique |
US6642409B2 (en) | 2000-01-27 | 2003-11-04 | Central Glass Company, Limited | Process for producing 4,4,4-trifluoro-3-hydroxybutyric acid derivatives |
US6444813B2 (en) * | 2000-02-02 | 2002-09-03 | Pharmacia & Upjohn Company | Linezolid-crystal form II |
WO2002018354A1 (en) * | 2000-08-31 | 2002-03-07 | Abbott Laboratories | Oxazolidinones and their use as antibacterial agents |
EP2266590A3 (de) | 2002-02-22 | 2011-04-20 | Shire LLC | Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU80081A1 (fr) * | 1977-08-26 | 1979-05-15 | Delalande Sa | Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique |
FR2506769A2 (fr) * | 1978-06-09 | 1982-12-03 | Delalande Sa | Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique |
US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
FR2458547B2 (fr) * | 1978-06-09 | 1986-05-16 | Delalande Sa | Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique |
CA1171865A (en) * | 1980-06-04 | 1984-07-31 | Alain Lacour | N-aryl azolone derivatives, the process for preparing the same and their application in therapeutics |
FR2608604B1 (fr) * | 1986-12-19 | 1989-04-28 | Delalande Sa | Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique |
FR2653017B1 (fr) * | 1989-10-17 | 1995-05-05 | Delalande Sa | Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique. |
-
1989
- 1989-10-17 FR FR8913555A patent/FR2653017B1/fr not_active Expired - Fee Related
-
1990
- 1990-10-15 US US07/597,583 patent/US5036091A/en not_active Expired - Lifetime
- 1990-10-15 US US07/597,426 patent/US5036090A/en not_active Expired - Fee Related
- 1990-10-16 EP EP90402892A patent/EP0424244B1/de not_active Expired - Lifetime
- 1990-10-16 AT AT90402891T patent/ATE126792T1/de active
- 1990-10-16 CA CA002027783A patent/CA2027783C/en not_active Expired - Lifetime
- 1990-10-16 US US07/598,254 patent/US5171747A/en not_active Expired - Fee Related
- 1990-10-16 EP EP90402893A patent/EP0428421A1/de not_active Withdrawn
- 1990-10-16 EP EP90402891A patent/EP0424243B1/de not_active Expired - Lifetime
- 1990-10-16 CA CA002027715A patent/CA2027715A1/en not_active Abandoned
- 1990-10-16 ES ES90402892T patent/ES2078958T3/es not_active Expired - Lifetime
- 1990-10-16 DE DE69021823T patent/DE69021823T2/de not_active Expired - Fee Related
- 1990-10-16 DE DE69021498T patent/DE69021498T2/de not_active Expired - Lifetime
- 1990-10-16 DK DK90402892.5T patent/DK0424244T3/da active
- 1990-10-16 CA CA002027782A patent/CA2027782C/en not_active Expired - Fee Related
- 1990-10-16 AT AT90402892T patent/ATE126220T1/de not_active IP Right Cessation
- 1990-10-17 NZ NZ235728A patent/NZ235728A/en unknown
- 1990-10-17 JP JP2514789A patent/JPH04502335A/ja active Pending
- 1990-10-17 WO PCT/FR1990/000746 patent/WO1991005775A1/fr active Application Filing
- 1990-10-17 JP JP2514788A patent/JPH07103114B2/ja not_active Expired - Lifetime
- 1990-10-17 AU AU64713/90A patent/AU637150B2/en not_active Ceased
- 1990-10-17 KR KR1019910700619A patent/KR0149508B1/ko not_active IP Right Cessation
- 1990-10-17 JP JP2514787A patent/JPH04502333A/ja active Pending
- 1990-10-17 WO PCT/FR1990/000745 patent/WO1991005774A1/fr unknown
- 1990-10-17 ZA ZA908283A patent/ZA908283B/xx unknown
- 1990-10-17 WO PCT/FR1990/000747 patent/WO1991005776A1/fr unknown
- 1990-10-17 ZA ZA908284A patent/ZA908284B/xx unknown
- 1990-10-17 KR KR1019910700620A patent/KR920701178A/ko not_active Application Discontinuation
- 1990-10-17 NZ NZ235727A patent/NZ235727A/en unknown
- 1990-10-17 NZ NZ235729A patent/NZ235729A/en unknown
- 1990-10-17 AU AU64714/90A patent/AU637413B2/en not_active Expired
- 1990-10-17 KR KR1019910700618A patent/KR920701176A/ko active IP Right Grant
- 1990-10-17 AU AU64715/90A patent/AU635779B2/en not_active Ceased
- 1990-10-17 ZA ZA908285A patent/ZA908285B/xx unknown
-
1995
- 1995-10-11 GR GR950402817T patent/GR3017708T3/el unknown
-
1998
- 1998-06-02 HK HK98104744A patent/HK1005591A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE126792T1 (de) | 3-aryl-oxazolidinone, verfahren zu ihrer herstellung und ihre anwendung in der therapie. | |
ATE51231T1 (de) | Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als antiallergische mittel. | |
ATE82262T1 (de) | Piperidin-derivate. | |
WO1995001170A3 (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
DE69227583T2 (de) | Arylmorpholine, herstellung und verwendung | |
ATE2431T1 (de) | 2,3-dihydroimidazo (1,2-b) pyridazin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. | |
ATE42291T1 (de) | Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. | |
DE59005819D1 (de) | 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. |